BeiGene SSE – BeiGene Shanghai Investors

Our mission is to build the first next-generation biopharmaceutical company — one that expands the highest quality therapies to billions more people — through courage, persistent innovation, and challenging the status quo.

All Documents



Press Releases

May 17, 2022
BeiGene Strengthens European Presence With the Opening of Regional Office in Basel, Switzerland    read more...
May 12, 2022
BeiGene to Demonstrate Strength of Hematology Portfolio and Pipeline at European Hematology Association 2022 Congress    read more...
May 05, 2022
BeiGene Reports First Quarter 2022 Financial Results   
Press Releases

Thank you for your interest in Beigene, Ltd ! You will receive an email shortly. Please confirm your email address by clicking the link inside.

Back to the form